ArticleInflammopharmacology2025
Evaluation of anti-inflammatory and anti-oxidant properties of Anacardium occidentale leaf.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Systematic Literature Review of Functional Snacks: Bioactive Properties, Food Technologies, and Consumer Acceptance.Foods (Basel, Switzerland) · 2026Review
- Innovation and Biodiversity: Patent Trends in Therapeutic and Cosmetic Use of Scientifically Relevant Pantanal Plants.Plants (Basel, Switzerland) · 2026Review
- Assessment of the effect of Lasianthera africana on Interleukin-6, tumor necrosis factor-alpha and other inflammatory markers in inflamed wistar rats.Inflammopharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammation is a critical factor in various chronic diseases, and the search for natural anti-inflammatory agents has gained attention. This study investigates the anti-inflammatory potential of Anacardium occidentale (cashew) leaf extract. A preliminary phytochemical screening revealed the presence of bioactive compounds, with alkaloids (1.667 ± 0.004 mg/ml) and saponins (1.568 ± 0.001 mg/ml) as the most abundant. These compounds, along with flavonoids, phenolics, terpenoids, and steroids, are known for their pharmacological properties, including inflammation modulation. The study utilized various antioxidant assays, including DPPH, FRAP, and total antioxidant capacity (TAC), which demonstrated significant radical scavenging activity, indicating the extract's potential to reduce oxidative stress-induced inflammation. The ethanol extract exhibited notable inhibition of protein denaturation, protease activity, lipid peroxidation, nitric oxide scavenging, and phospholipase A
Indexed as
Identifiers
40474029What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.